{
  "id": 2369559,
  "title": "Replimune lands commercial chief after hard-fought approval; Neumora's Paul Berns sheds CEO title",
  "url": "https://urgent.news/2026/08/21/replimune-lands-commercial-chief-after-hard-fought-approval-neumoras",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T11:00:44.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/replimune-lands-commercial-chief-after-hard-fought-approval-neumora-changes-ceos-names-cmo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer, effective Aug. 18. DiNapoli formerly worked at Genentech and led ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}